Lexin Shu
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Traditional Chinese Medicine Analysis 8
-
- Pharmacological Effects of Natural Compounds 2
Lexin Shu
20 papers receiving 312 citations
Peers
Comparison fields: 5 of 64
- Pharmaceutical Science 91
- Complementary and alternative medicine 48
- Pharmacology 38
- Pharmacology 48
- Biomaterials 32
Countries citing papers authored by Lexin Shu
This map shows the geographic impact of Lexin Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lexin Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexin Shu more than expected).
Fields of papers citing papers by Lexin Shu
This network shows the impact of papers produced by Lexin Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lexin Shu. The network helps show where Lexin Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lexin Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 44 | |
| 15 | 2020 | 32 | |
| 16 | Tissue distribution study of salvianolic acid B long-circulating liposomes in mice by UPLC-MS/MS determination. | 2015 | 3 |
| 17 | 2015 | 62 | |
| 18 | 2010 | 81 | |
| 19 | Determination of total saponins in anti-inflammatory and antasthmatic extractum | 2009 | 1 |
| 20 | 2009 | 32 |
About Lexin Shu
Lexin Shu is a scholar working on Complementary and alternative medicine, Pharmacology, Analytical Chemistry, Biological Psychiatry and Pharmaceutical Science, having authored 22 papers that have together received 317 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (10 papers), Traditional Chinese Medicine Analysis (8 papers), Phytochemistry and Biological Activities (6 papers), Chromatography in Natural Products (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Plant chemical constituents analysis (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (91 citations), Complementary and alternative medicine (48 citations), Pharmacology (38 citations), Pharmacology (48 citations) and Biomaterials (32 citations). Lexin Shu has collaborated with scholars based in China. Frequent co-authors include Zhidong Liu, Yubo Li, Xinhua Zhang, Jiawei Li, Simiao Fan, Haoyun Wu, Nan Li, Lin Li, Rui Liu and Yuming Wang. Their work appears in journals such as Journal of Mass Spectrometry, Journal of Separation Science, Rapid Communications in Mass Spectrometry, Drug Design Development and Therapy and Fitoterapia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.